Dumas Jacques 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Apr 4, 2018
Insider Transaction Report
Form 4
Dumas Jacques
Chief ScientificOfficer
Transactions
- Award
Restricted Stock Units
2018-04-02+40,000→ 40,000 total→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F2]The restricted stock units vest in two equal installments on each of April 2, 2019 and April 2, 2020.